Disc Medicine Inc (IRON) has a current Price-to-Book (P/B) ratio of 4.83. Compared to its 3-year average P/B ratio of 3.41, the current P/B ratio is approximately 41.53% higher. Relative to its 5-year average P/B ratio of 3.34, the current P/B ratio is about 44.78% higher. Disc Medicine Inc (IRON) has a Forward Free Cash Flow (FCF) yield of approximately -5.56%. Compared to its 3-year average FCF yield of -6.28%, the current FCF yield is approximately -11.43% lower. Relative to its 5-year average FCF yield of -6.56%, the current FCF yield is about -15.23% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for IRON competitors is 213.46, providing a benchmark for relative valuation. Disc Medicine Inc Corp (IRON.O) exhibits a P/S ratio of 169.28, which is -20.7% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of IRON increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of IRON in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is IRON currently overvalued or undervalued?

What is Disc Medicine Inc (IRON) fair value?

IRON's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Disc Medicine Inc (IRON) is between to according to relative valuation method.

How does IRON's valuation metrics compare to the industry average?

The average P/S ratio for IRON's competitors is 213.46, providing a benchmark for relative valuation. Disc Medicine Inc Corp (IRON) exhibits a P/S ratio of 169.28, which is -20.70% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Disc Medicine Inc (IRON) as of Mar 04 2026?

As of Mar 04 2026, Disc Medicine Inc (IRON) has a P/B ratio of 4.83. This indicates that the market values IRON at 4.83 times its book value.

What is the current FCF Yield for Disc Medicine Inc (IRON) as of Mar 04 2026?

As of Mar 04 2026, Disc Medicine Inc (IRON) has a FCF Yield of -5.56%. This means that for every dollar of Disc Medicine Inc's market capitalization, the company generates -5.56 cents in free cash flow.

What is the current Forward P/E ratio for Disc Medicine Inc (IRON) as of Mar 04 2026?

As of Mar 04 2026, Disc Medicine Inc (IRON) has a Forward P/E ratio of -11.69. This means the market is willing to pay $-11.69 for every dollar of Disc Medicine Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Disc Medicine Inc (IRON) as of Mar 04 2026?

As of Mar 04 2026, Disc Medicine Inc (IRON) has a Forward P/S ratio of 169.28. This means the market is valuing IRON at $169.28 for every dollar of expected revenue over the next 12 months.

IRON Valuation